Dec 27, 2018 12:11 PM IST
We expect the stock to resume fresh up move and test levels of Rs 8450 levels in the medium term, says Dharmesh Shah of ICICI Securities.
- Nov 14, 2018 10:02 AM IST
- Nov 13, 2018 10:38 PM IST
Revenue from operations stood at Rs 979.72 crore for the quarter under consideration against Rs 930.98 crore for the same period a year ago.
- Oct 11, 2018 05:18 PM IST
Centrum recommended hold rating on Abbott India with a target price of Rs 7250 in its research report dated October 10, 2018.
- Aug 26, 2018 12:07 PM IST
The Mumbai-based firm, which is a subsidiary of US-based Abbott Laboratories, had launched 21 new products in the country last fiscal.
- May 23, 2018 03:58 PM IST
Centrum is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 7530 in its research report dated May 15, 2018.
- Apr 02, 2018 05:30 PM IST
Both these brands are popular prescription drugs to manage diabetes and hyperthyroidism, Tejas Kothari, Head-Strategy at Corona said.
- Nov 13, 2017 01:46 PM IST
It had posted a net profit of Rs 75.02 crore for the corresponding period of last fiscal, Abbott India said in a filing to BSE.
- Oct 03, 2017 07:57 AM IST
According to Technical Analyst Prakash Gaba of prakashgaba.com, expect a gap up opening with crucial support for the Nifty at 9596 and resistance at 9816-9946. On the other hand Bank Nifty has support at 23720 and resistance at 24312.
- Aug 08, 2017 03:19 PM IST
The company had posted net profit of Rs 74.01 crore in the same quarter last fiscal, Abbott India said in a BSE filing.
- Mar 31, 2017 01:29 PM IST
Just Dial lost nearly 30 per cent, followed by Wockhardt which dropped 25 percent, Reliance Communication slipped 22 percent, and Tata Elxsi plunged 21 percent in the same period.
- Feb 23, 2017 09:10 PM IST
As many as 634 drugs of various
strengths produced by firms, including Cipla, Abbott,
Astrazeneca and Dr Reddy's, are "suspected" to be
non-compliant with ceiling prices as notified by NPPA.
- Feb 10, 2017 03:05 PM IST
Centrum is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 5380 in its research report dated February 06, 2017.
- Feb 06, 2017 02:14 PM IST
Its standalone total income from operations also rose to Rs 755.72 crore during the quarter from Rs 669.52 crore in the same period a year ago.
- Jan 14, 2017 02:00 PM IST
Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounded annual growth rate (CAGR) over last 10 years
- Jan 09, 2017 08:18 PM IST
The domestic drug market grew at 7.2 percent in December, compared to 15.5 percent growth in November due to slowdown in uptake of chronic portfolio and contraction in acute segment. The pharma market clocked Rs.9.132 crores in December.
- Dec 13, 2016 08:01 AM IST
Axis Bank | Tata Motors | Sun Pharma | IRB Infrastructure | Sunteck Realty | NIIT | Fortis Healthcare | Abbot India | APL Apollo Tubes | Aarey Drugs | PAE | MEP Infra and Bajaj Finance are stocks, which are in the news today.
- Dec 01, 2016 10:37 AM IST
Centrum recommended hold rating on Abbott India with a target price of Rs 4480 in its research report dated November 28, 2016.
- Nov 28, 2016 08:01 AM IST
Bharti Airtel | Cipla | GAIL | Idea Cellular | Apollo Tyres | Tata Elxsi | Aurobindo Pharma | Uflex | Dilip Buildcon | ARSS Infra | GPT Infra | Strides Shasun | Ashok Leyland and Ricoh India are stocks, which are in the news today.
- Oct 19, 2016 02:34 PM IST
Net Sales are expected to increase by 2 percent Q-o-Q (up 16.7 percent Y-o-Y) to Rs 752.5 crore, according to Centrum.
- Sep 29, 2016 01:00 PM IST
"The board at its meeting held today approved the appointment of Ambati Venu as an additional director on the board and managing director of the company for a term of 5 years effective September 29, 2016, subject to approval from the central government and shareholders of the company," Abbott India said in a BSE filing.
- Aug 26, 2016 06:32 PM IST
The company had posted a net profit of Rs 67.31 crore for the similar quarter last year, Abbott said in a BSE filing.
- Jul 08, 2016 08:01 AM IST
Tata Motors | DLF | Tata Steel | Gujarat Gas | Sobha | Aurobindo Pharma | Mahindra Holidays | Lupin | Palred Tech | Ricoh India | Astec | Garware Wall Ropes | Indian Hotels | MMTC | GTL Infra Projects | Viji Financehjmun | Vedanta | Hanung Toys | Indo Count and Zee Learn are stocks, which are in the news today.
- May 26, 2016 08:14 AM IST
Tata Steel | Larsen and Toubro | Kaveri Seed | Monsanto | KNR Construction | Ruchi Soya | VRL Logistics | NALCO | IL&FS Transportation | Power Grid and GAIL are stocks, which are in the news today.
- May 25, 2016 09:22 PM IST
Drug firm Abbott India today
reported an 18.58 per cent rise in its standalone net profit
to Rs 59.01 crore for the fourth quarter ended March 2016,
mainly on account of robust sales.